(Q36002272)

English

Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a Phase III trial of mometasone cream versus placebo during breast radiotherapy: the North Central Cancer Treatment Group (N06C4).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a Phase III trial of mometasone cream versus placebo during breast radiotherapy: the North Central Cancer Treatment Group (N06C4). (English)

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

phase III clinical trial

0 references

0 references

Pamela J Atherton

2

object named as

Pamela J Atherton

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

author name string

Michelle A Neben-Wittich

1

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

David J Schwartz

3

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Jeff A Sloan

4

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Patricia C Griffin

5

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Richard L Deming

6

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Jon C Anders

7

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Charles L Loprinzi

8

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Kelli N Burger

9

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

James A Martenson

10

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Robert C Miller

11

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

language of work or name

0 references

publication date

1 October 2010

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

81

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

2

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

397-402

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365545

2 October 2017

Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365545

2 October 2017

Patient-reported outcomes assessment in cancer trials: taking stock, moving forward

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365545

2 October 2017

Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365545

2 October 2017

Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networks

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365545

2 October 2017

Validation of single-item linear analog scale assessment of quality of life in neuro-oncology patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365545

2 October 2017

A pooled analysis of quality of life measures and adverse events data in north central cancer treatment group lung cancer clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365545

2 October 2017

Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365545

2 October 2017

Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365545

2 October 2017

Reflections on findings of the Cancer Outcomes Measurement Working Group: moving to the next phase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365545

2 October 2017

CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365545

2 October 2017

Assessing the reliability of two toxicity scales: implications for interpreting toxicity data.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365545

2 October 2017

The palliation of symptomatic osseous metastases: final results of the Study by the Radiation Therapy Oncology Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365545

2 October 2017

Issues for statisticians in conducting analyses and translating results for quality of life end points in clinical trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365545

11 July 2018

Effects of treatment intensification on acute local toxicity during radiotherapy for head and neck cancer: prospective observational study validating CTCAE, version 3.0, scoring system.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365545

23 September 2018

Patient online self-reporting of toxicity symptoms during chemotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365545

23 September 2018

Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365545

23 September 2018

[Reliability at the National Cancer Institute-Common Toxicity Criteria version 2.0].

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365545

23 September 2018

Quality of life as a survival predictor for esophageal squamous cell carcinoma treated with radiotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365545

23 September 2018

Supportive use of megestrol acetate (Megace) with head/neck and lung cancer patients receiving radiation therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365545

23 September 2018

Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3365545

23 September 2018

Is cancer treatment toxicity accurately reported?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20888137

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Challenges in QOL assessment. Overview and introduction

1 reference

https://pubmed.ncbi.nlm.nih.gov/20888137

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Mayo Clinic manuscript series relative to the discussion, dissemination, and operationalization of the Food and Drug Administration guidance on patient-reported outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20888137

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.IJROBP.2010.05.065

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36002272&oldid=1597973094"